Skip to main content
Clinical Trials/NCT06336850
NCT06336850
Recruiting
Not Applicable

Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement

Methodist Health System1 site in 1 country100 target enrollmentDecember 23, 2020
ConditionsLiver Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Liver Diseases
Sponsor
Methodist Health System
Enrollment
100
Locations
1
Primary Endpoint
Portal Pressure Gradient Measurements from Hepatic and Portal Veins
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the efficacy, safety, and adequacy of Endoscopic Ultrasound (EUS) Portal Pressure Gradient Measurement (PPGM) in patients undergoing EUS-guided liver biopsies.

Detailed Description

Patients undergoing EUS-guided liver biopsy may qualify to participate in this study. The purpose of this study is to evaluate the efficacy, safety, and adequacy of EUS- Portal Pressure Gradient Measurement (PPGM) in patients with liver disease referred for EUS-guided liver biopsy.

Registry
clinicaltrials.gov
Start Date
December 23, 2020
End Date
January 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Portal Pressure Gradient Measurements from Hepatic and Portal Veins

Time Frame: 2 years

A catheter is inserted into the hepatic vein before hepatic venous pressure and portal vein pressure are recorded

Secondary Outcomes

  • Correlation between Portal Pressure Gradient Measurements and the presence or absence of portal hypertension(2 years)
  • Clinical significance between portal pressure gradient measurement and portal hypertension(2 years)

Study Sites (1)

Loading locations...

Similar Trials